Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015)
Voyager Therapeutics recorded quarterly Preferred Dividend Payments of -$4.8 million in Q4 2015, down 285.04% quarter-over-quarter from $2.6 million in Q3 2015, and down 1046.75% year-over-year from $507000.0 in Q4 2014.
Voyager Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at -$4.8 million for Q4 2015.
- In Q4 2015, Preferred Dividend Payments fell 1046.75% year-over-year to -$4.8 million; the TTM figure through Dec 2015 stood at $483000.0 (changed N/A YoY), while the FY2016 annual figure was $1.2 million, down 3.61% from the prior year.
- Preferred Dividend Payments came in at -$4.8 million for Q4 2015 at Voyager Therapeutics, down from $2.6 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.6 million in Q3 2015 to a low of -$4.8 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -4.80 Mn |
| Sep 30, 2015 | 2.59 Mn |
| Jun 30, 2015 | 2.45 Mn |
| Mar 31, 2015 | 237,000.00 |
| Dec 31, 2014 | 507,000.00 |
| Sep 30, 2014 | 406,000.00 |